Cover Story
Pat Dwyer of Kenmore, Wash., uses three different devices to make sure he’s getting enough air. A “sip-and-puff” ventilator supplements his breathing efforts during the day; bilevel positive airway pr...
Featured Articles
Dexpramipexole shows efficacy in ALS
Newly published data confirm that in a two-part phase 2 clinical trial, the experimental therapy dexpramipexole showed dose-related slowing of symptom progression...
One of the first things that comes with a diagnosis of ALS is the determination of which “form” a person has: familial or sporadic.
Sometimes it appears obvious. If there’s a known history of the...
Fight smart, not just hard. That’s the motto of Richard Bedlack, a world-renowned ALS research warrior who directs the ALS Clinic at Duke University, Durham, N.C. “Everyone I’ve ever met who is...
ALS
- Indications of Safety, Efficacy in BrainStorm Stem Cell Trial
- ALS Biomarkers Study Seeks 250 Participants
- Immunomodulator CTLA4-FC Being Tested in ALS Mouse Model
- ALS TDI Teams with Two Biotechs to Develop Therapy
- Phase 2 Trial of ALS Drug Yields Encouraging Results
- Gerald C. Weinberg Retires as MDA President and CEO
- Scholarships Offered to Students with a Parent with ALS
- Dexpramipexole Phase 2 Results Show Efficacy in ALS
- ALS TDI Summit: 'An Incredibly Hopeful Time'
- ALS Clinical Trials Briefs: Cytokinetics, Neuralstem Advance
All of contents copyright 2010 MDA All rights reserved.
